Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

9473	Companies
185388	Keywords
117743	Articles
99274	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

PRESS RELEASE

published on 04/01/2025 at 07:00, 8 months 4 days ago

Newron presents 2024 financial results and provides 2025 outlook
Newron Pharmaceuticals presents 2024 financial results and 2025 outlook, focusing on evenamide development for schizophrenia treatment and strategic licensing agreements

Financial Results Newron Pharmaceuticals Evenamide Licensing Agreements 2025 Outlook
BRIEF

published on 03/24/2025 at 17:50, 8 months 11 days ago

Newron Pharmaceuticals nomme le Dr Chris Martin au poste de président indépendant

Conseil D'administration Newron Pharmaceuticals Chris Martin Leadership Biopharmaceutique Thérapie De La Schizophrénie
BRIEF

published on 03/24/2025 at 17:50, 8 months 11 days ago

Newron Pharmaceuticals Nominates Dr. Chris Martin as Independent Chairman

Board Of Directors Newron Pharmaceuticals Chris Martin Biopharma Leadership Schizophrenia Therapy
PRESS RELEASE

published on 03/24/2025 at 17:45, 8 months 11 days ago

Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
Newron Pharmaceuticals S.p.A. proposes Chris Martin, ex-CEO of ADC Therapeutics, as Independent Chairman succeeding Dr. Köstlin after 12 years. Martin an experienced biopharma leader

Chairman Biopharma Newron Pharmaceuticals Chris Martin ADC Therapeutics
BRIEF

published on 01/09/2025 at 07:05, 10 months 27 days ago

Accord de licence entre Newron et Myung In Pharm pour l'Evenamide en Corée du Sud

Evenamide Traitement De La Schizophrénie Contrat De Licence Essai De Phase III Thérapies Du Système Nerveux Central
BRIEF

published on 01/09/2025 at 07:05, 10 months 27 days ago

Newron and Myung In Pharm License Agreement for Evenamide in South Korea

Phase III Trial CNS Therapies Evenamide Schizophrenia Treatment License Agreement
PRESS RELEASE

published on 01/09/2025 at 07:00, 10 months 27 days ago

Newron and Myung In Pharm announce license agreement for evenamide in South Korea
Newron Pharmaceuticals S.p.A. and Myung In Pharm enter license agreement for evenamide in South Korea, aiming to develop innovative treatment option for schizophrenia patients

Newron Pharmaceuticals Evenamide License Agreement South Korea Myung In Pharm
BRIEF

published on 12/13/2024 at 07:05, 11 months 23 days ago

Newron and EA Pharma Sign License Agreement for Evenamide in Asia

Newron Pharmaceuticals Evenamide Schizophrenia Treatment License Agreement EA Pharma
BRIEF

published on 12/13/2024 at 07:05, 11 months 23 days ago

Newron et EA Pharma signent un accord de licence pour Evenamide en Asie

Evenamide Traitement De La Schizophrénie Contrat De Licence Newron Pharmaceutique EA Pharma
PRESS RELEASE

published on 12/13/2024 at 07:00, 11 months 23 days ago

Newron and EA Pharma (a subsidiary of Eisai Co., Ltd.) announce license agreement for evenamide in Japan and other Asian territories
Newron Pharmaceuticals S.p.A. and EA Pharma (a subsidiary of Eisai Co., Ltd.) have signed a license agreement for evenamide in Japan and other Asian territories, aiming to address unmet medical needs in patients with schizophrenia

Schizophrenia Newron Pharmaceuticals Evenamide License Agreement EA Pharma

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 59 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 4 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 34 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 29 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 34 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 29 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 33 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 33 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 34 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 34 minutes ago

Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions

Les Echos

Published on 12/04/2025 at 18:14, 14 hours 19 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 34 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 34 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 49 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 49 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE